The task order to the CIADM includes accelerating expansion of that manufacturing capacity for potential COVID-19 vaccines.
With this task order, the U.S. government has reserved the CIADM's capacity through December 2021 for U.S. government partners developing vaccines, such as Novavax, under. The task order also enables FUJIFILM Diosynth Biotechnologies to more rapidly expand production capacity for vaccine manufacturing at the company's CIADM facilities in Texas.
tamusystem Gridlock at HHS
tamusystem Should just share the traditional/natural antiviral approaches. They exist in history; during times of widespread health. If a company disguised them, internally first, would HHS notice? (Health - it's a fact thing, not a profit motivated fiction thing.)
tamusystem Good.